Trial intelligence / Profile preview

Remimazolam vs Propofol for Long-term Sedation in ICU

NCT05555667Phase 3Recruiting

Start
May 2023
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam in sedation. Started May 2023; status: recruiting.

02

Drugs

remimazolam
03

Conditions

sedation

Beyond the preview

Go deeper on NCT05555667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05555667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call